Coronavirus Disease PHGKB|Home|PHGKB

Coronavirus Disease PHGKB|Home|PHGKB

 Spotlight on COVID-19

Rapid implementation of mobile technology for real-time epidemiology of COVID-19
DA Drew et al, MEDRXIV, April 6, 2020

The COronavirus Pandemic Epidemiology (COPE) consortium brings together scientists with expertise in big data research and epidemiology to develop a COVID-19 Symptom Tracker mobile application garnering more than 2.25 million users to date. This mobile application offers data on risk factors, herald symptoms, clinical outcomes, and geographical hot spots.

COVID-19 PM2.5: A national study on long-term exposure to air pollution and COVID-19 mortality in the United States
Harvard University, April 6, 2020

Data was collected for approximately 3,000 counties in the United States (98% of the population) up to April 04, 2020. The study found that an increase of only 1 µg/m3 in PM2.5 is associated with a 15% increase in the COVID-19 death rate, 95% confidence interval (CI) (5%, 25%). Results are statistically significant and robust to secondary and sensitivity analyses.

Coronavirus Disease 2019 and Children: What Pediatric Health Care Clinicians Need to Know
SA Rasmussen et al, JAMA Pediatrics, April 5, 2020

While early data suggest that #COVID19 effects on children are less severe than those on adults, yet many questions remain, especially regarding the effects on children with special health care needs.

Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020
CDC MMWR, April 6, 2020

Among 345 pediatric cases, 80 (23%) had at least one underlying condition. The most common underlying conditions were chronic lung disease (including asthma) (40), cardiovascular disease (25), and immunosuppression (10). 77% of hospitalized patients, including all six patients admitted to an ICU, had one or more underlying medical condition.